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Swine inﬂuenzaWe have utilized glycan microarray technology to determine the receptor binding properties of early isolates
from the recent 2009 H1N1 human pandemic (pdmH1N1), and compared them to North American swine
inﬂuenza isolates from the same year, as well as past seasonal H1N1 human isolates. We showed that the
pdmH1N1 strains, as well as the swine inﬂuenza isolates examined, bound almost exclusively to glycans with
α2,6-linked sialic acid with little binding detected for α2,3-linked species. This is highlighted by pair-wise
comparisons between compounds with identical glycan backbones, differing only in the chemistry of their
terminal linkages. The overall similarities in receptor binding proﬁles displayed by pdmH1N1 strains and
swine isolates indicate that little or no adaptation appeared to be necessary in the binding component of HA
for transmission from pig to human, and subsequent human to human spread.r).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
According to the World Health Organization, the viruses respon-
sible for the recent human outbreak of the 2009 H1N1 pandemic
subtype (pdmH1N1) were ﬁrst detected in North America in April of
2009, have since been isolated in more than 200 countries, and have
caused greater than 18,000 deaths worldwide. The pandemic H1N1
strains are composed of six segments derived from a triple reassortant
swine H1N1 strain (trH1N1), and two segments from the Eurasian
“avian-like” swine H1N1 viruses (Garten et al., 2009). Initially, there
were concerns that the new human strains were highly pathogenic,
due to a high mortality rate of infected patients with complications in
a Mexico City hospital (Domínguez-Cherit et al., 2009; Fraser et al.,
2009). However, as the virus spread through the United States, the
majority of symptomatic infections were found to result in uncom-
plicated, upper respiratory tract illness with a relatively lowmortality
rate. The newly emergent H1N1 strains rapidly spreadworldwide, and
the pdmH1N1 outbreakwas declared a phase 6 pandemic by theWHO
in June 2010 (Dawood et al., 2009). Despite the fact that pandemicH1N1 viruses (pdmH1N1) are not recognized as highly pathogenic in
the classical sense, certain features of their disease proﬁle appear to
differ from the seasonal H1N1 viruses that have circulated in humans
since 1977. They affected children and younger adults at much higher
rates than older adults and the elderly, likely as a result of immunity in
the population that had been exposed to H1N1 viruses that circulated
prior to 1957 (Hancock et al., 2009). In addition, the disease they
caused in children was often more serious than had been observed
with the previously circulating seasonal H1N1 strains (Bhat et al.,
2005; CDC, 2009; Louie et al., 2009), and had signiﬁcant effects in
terms of years of lost life (Viboud et al., 2010). For these reasons, the
characteristics of replication, transmission, and pathogenicity of
pdmH1N1 viruses and related human and swine viruses warrant
continued and detailed scrutiny.
The triple reassortant virus (trH1N1), which contributed 6 of the
8 gene segments in the pdmH1N1, is made up of segments from avian,
human, and swine viruses. The trH1N1 viruses emerged in swine in
the late 1990s and were ﬁrst reported in humans in 2005 (Olsen,
2002; Shinde et al., 2009). These strains periodically infected humans
through 2009, typically resulting in mild illness, but did not become
established in the human population (Shinde et al., 2009). Currently,
it is unclear when or where the reassortant event that combined the
six segments from the trH1N1 and the NA and M segments from the
Ta
bl
e
1
Re
ce
pt
or
bi
nd
in
g
si
te
se
qu
en
ce
al
ig
nm
en
t
of
st
ra
in
s
ex
am
in
ed
by
gl
yc
an
ar
ra
y
an
al
ys
is
(H
3
nu
m
be
ri
ng
).
19
5
19
4
19
3
19
2
19
1
19
0
18
6
18
3
13
8
13
7
13
6
13
5
13
4
13
3
St
ra
in
Su
bt
yp
e
A
Q
L
Y
R
A
A
/C
al
if
or
ni
a/
04
/2
00
9
K
T
A
A
H
S
S
A
/M
ex
ic
o/
IN
D
RE
44
87
/2
00
9
K
T
A
A
H
S
S
A
/T
ex
as
/1
5/
20
09
K
T
A
A
H
S
S
A
/S
w
/M
in
ne
so
ta
/0
27
49
/2
00
9
R
T
A
A
H
SN
N
Q
K
N
N D
Q
Q
D
Q
Q
D
Q
Q
D
Q
Q
S
A
/S
w
/M
in
ne
so
ta
/0
27
51
/2
00
9
K
T
A
A
N
Q
R
H
3N
1 
W
T
N
G
G
S
H
Q
A
/S
w
/M
in
ne
so
ta
/0
27
19
 (
H
3N
2)
D
G
S
S
H
GS
E
T
S
D
Q
T
N
23
0
22
9
22
8
22
7
22
6
22
5
22
4
22
3
22
2
22
1
22
0
21
9
21
8
21
7
I
M
I
M
A
I
I
M
T
A
M
V
A
M
T
I
W
A
/P
en
ns
yl
va
ni
a/
08
/2
00
8
T
G
V
S
A
S
H
P
D
Q
K
T
L
Y
A
/B
ri
sb
an
e/
59
/2
00
7
T
G
V
S
A
S
H
A
/N
ew
 C
al
ed
on
ia
/2
0/
19
99
T
G
V
S
A
S
H
L
Y
G
V
L
Y
G
V
L
Y
G
V
L
Y
G
V
L
Y
G
V
H
P
D
Q
Q
T
L
Y
A
/S
w
/I
lli
no
is
/0
28
60
/2
00
9
T
G
V
S
A
S
H
P
T
L
Y
N
A
L
Y
Y
A
L
Y
I
A
K
R
P
K
V
R
D
Q
E
G
R
I
I
A
K
R
P
K
V
R
D
Q
E
G
R
I
I
A
K
R
P
K
V
R
D
Q
E
G
R
I
I
A
R
P
K
V
R
D
Q
E
G
R
I
A
R
P
K
V
R
D
Q
E
G
R
R
P
K
V
R
D
Q
E
G
R
I
A
R
P
K
V
R
D
Q
I
A
R
P
K
V
R
D
Q
I
K
R
P
K
V
R
D
Q
E
G
R
I
I
G
S
R
P
G
S
R
P
W
G
R
G
R
L
S
S
R
I
V
R
G
V
R
G
V
S
S
I
I
Re
si
du
e 
nu
m
be
r
13
0 
Lo
op
19
0 
H
el
ix
22
0 
Lo
op
H
3 
su
bt
yp
e
Se
as
on
al
 H
1N
1
SO
IV
 H
1N
1
Sw
in
e 
is
ol
at
es
 
(H
1N
1)
Re
si
du
es
w
hi
ch
di
ff
er
fr
om
th
e
re
fe
re
nc
e
st
ra
in
(A
/P
en
ns
yl
va
ni
a/
08
/2
00
8)
ar
e
la
be
le
d
in
re
d.
H
3N
1
W
T
re
fe
rs
to
a
la
bo
ra
to
ry
vi
ru
s
w
it
h
th
e
H
A
fr
om
A
/A
ic
hi
/2
/6
8
on
a
A
/W
SN
/3
4
ge
ne
ti
c
ba
ck
gr
ou
nd
.
170 K.C. Bradley et al. / Virology 413 (2011) 169–182Eurasian H1N1 swine inﬂuenza viruses occurred, but phylogenetic
analysis has suggested the pandemic reassortant could have been
circulating undetected for several years (Smith et al., 2009).
Numerous studies have characterized the pathogenicity and trans-
missibility of the current pdmH1N1 strains in rodents, ferrets, and
swine, as well as the susceptibility of different age groups to the new
strain (Belser et al., 2010; Brookes et al., 2010; Ge at al.; Hancock et al.,
2009; Itoh et al., 2009; Maines et al., 2009; Steel et al.), and in some
experimental settings it seems that pdmH1N1 isolates can replicate
more efﬁciently in the lower respiratory tract compared to seasonal
H1N1 strains. Such studies suggest that the receptor binding
properties of pdmH1N1 may have unusual features by comparison
with other H1N1 viruses that have been characterized previously.
Inﬂuenza receptor binding is mediated by the hemagglutinin
glycoprotein (HA) and is thought to play a major role in the ability of
inﬂuenza to infect and propagate in a new species (Horimoto and
Kawaoka, 2005; Webster et al., 1992). Inﬂuenza binds to cell-surface
glycans containing N-acetylneuraminic acid (Neu5Ac) or its derivatives
(termed sialic acids) at their termini (Gottschalk, 1959;Klenk et al., 1955).
The linkage by which sialic acids are attached to the penultimate sugar of
the glycan is thought to play a role in host range speciﬁcity of inﬂuenza
viruses, often based onwhether this glycosidic bond is present in anα2,3
orα2,6 conformation (Connor et al., 1994; Ito andKawaoka, 2000; Rogers
and D'Souza, 1989; Skehel and Wiley, 2000). Inﬂuenza viruses isolated
from avian species commonly replicate in the gut and preferentially bind
α2,3-linked sialic acid (α2,3 SA), while inﬂuenza in humans is a
respiratory disease and tends to prefer α2,6-linked sialic acids (α2,6
SA). Swine contain an abundance of both α2,3 and α2,6 SA in their
respiratory tract (Ito and Kawaoka, 2000; Nelli et al., 2010) and therefore
are considered to be a potential “mixing vessel” for human, avian, and
other swine inﬂuenza strains (Scholtissek et al., 1985). In previous studies
using enzymatically modiﬁed erythrocytes, swine viruses have shown a
preference for α2,6 SA binding (Gambaryan et al., 2005; Rogers and
D'Souza, 1989; Takemae et al., 2010), and it is generally believed for an
avian or swine inﬂuenza strains to infect humans and transmit efﬁciently
fromperson to person, itmustﬁrst be able to bindα2,6 SA (Horimoto and
Kawaoka, 2005; Matrosovich et al., 2000).
Although there have been a selection of studies investigating the
bindingproperties of pdmH1N1viruses published recently (Childs et al.,
2009; Maines et al., 2009; Yang et al., 2010), we have chosen to expand
on these reports by conducting a comprehensive study of the binding
characteristics of pdmH1N1 viruses using glycan microarrays. For
comparative purposes, we include in these studies parallel analyses of
H1N1 swine inﬂuenza viruses that were isolated from pigs during the
same year of the pandemic outbreak, as well as seasonal H1N1 viruses
that circulated in humans before 2009. In addition to HA receptor-
binding characteristics, it is believed that a functional balance between
HA binding and neuraminidase (NA) enzymatic activity may occur
during adaptation to a new host possibly by improving transmission
efﬁciency of inﬂuenza viruses (Banks et al., 2001; Matrosovich et al.,
1999). TheNAof pdmH1N1 viruses is derived fromavian origins but has
been circulating in Eurasian swine for three decades. Therefore, to
evaluate the functional balance between HA and NA, we have also
examined the NA enzymatic activity of these viruses.
Results
Viruses examined
The details regarding initial transmission of pdmH1N1 to humans
have not been established, but the two strains of inﬂuenza virus that
combined to create the quadruple reassortant pandemic H1N1 virus
involved triple reassortant viruses (trH1N1) that had circulated in
North American swine since the late 1990s and Eurasian “avian-like”
H1N1 viruses, with HA genes being derived from the trH1N1 viruses
(Garten et al., 2009). For these studies, we assessed the receptor
Fig. 1. Schematic diagram of the HA receptor binding site and major structural
characteristics (dark blue), and the location of bound Neu5Acα2,6Gal (light blue) in the
binding pocket. The arrow indicates the α2,6 glycosidic linkage, and the yellow balls
show the locations of residues that differ among strains analyzed in this study and
discussed in the text. The white ball indicates residue 190, which is known to affect
receptor binding, but does not differ between pdmH1N1 and trH1N1 swine isolates. All
numbering is based on H3 the subtype prototype HA from A/Aichi/2/68 virus.
Table 2
Agglutination of erythrocytes by puriﬁed inﬂuenza strains.
Subtype Virus Erythrocytes
Chicken Turkey Horse Guinea
pig
Seasonal
H1N1
A/Brisbane/59/2007 1024 1024 0 2048
A/New Caledonia/20/1999 512 256 16 2048
A/Pennsylvania/08/2008 1024 1024 16 2048
SOIV H1N1 A/California/04/09 64 256 0 1024
A/Texas/15/2009 16 64 0 256
A/Mexico/INDRE4487/2009 32 128 0 512
Swine isolates
(H1N1)
A/Swine Iowa/1976/1931 128 128 0 2048
A/Swine/Minnesota/02749/
2009
64 512 0 2048
A/Swine/Minnesota/02751/
2009
128 256 0 256
A/Swine/Illinois/02860/2009 16 64 0 64
H3 Subtype H3N1 WT 128 128 0 256
A/Swine/Minnesota/02719/
2009 (H3N2)
128 512 0 1024
HA assays were performed using 0.5% erythrocytes from each animal, as described in
the Materials and Methods.
171K.C. Bradley et al. / Virology 413 (2011) 169–182binding properties of three 2009 human pandemic H1N1 strains, three
contemporary strains of 2009 swine isolate trH1N1 viruses, and three
seasonal human H1N1 strains that had circulated in previous years.
We also examined the classical 1931 swine H1N1 isolate A/swine/
Iowa/1976/31, and two H3N2 viruses for comparative purposes.
Inﬂuenza isolates are routinely ampliﬁed in embryonated chicken
eggs; however, it is well established that viruses passaged in eggs
have a propensity to select for mutations in the HA receptor binding
region that may alter the HA afﬁnity for various sialic acid containing
cell surface receptors (Burnet and Bull, 1943; Gambaryan et al., 1999;
Katz et al., 1990; Katz and Webster, 1988; Lugovtsev et al., 2009;
Robertson et al., 1987, 1985; Stevens et al., 2010). Therefore, we
utilized minimal passage in MDCK cells to amplify viruses whenever
possible, and the HA and NA genes for stock viruses were sequenced
and compared to the sequences obtained from initial isolates as well
as published sequences to ensure against laboratory-generatedFig. 2. Basic phylogenetic tree of related inﬂuenza isolates, as well as isolates utilized in th
building neighbor-joining methodology with no outgroups. Strains marked with a red asteselection of viruses with altered binding characteristics. The A/
Brisbane/59/2007 and A/New Caledonia/20/1999 human vaccine
strains, as well as the 1931 swine isolate A/Swine/Iowa/1976/1931
were included in this study for comparative purposes, but their
passage histories are not well documented, and almost certainly
include propagation in eggs at some stage. The viruses and their
sequences at HA positions known to be relevant for receptor binding
properties are shown in Table 1. Fig. 1 shows the structure of the H1
pdmH1N1 A/California/04/2009 receptor binding site (Xu et al., 2010)
and highlights the locations of residues pertinent to this study. Fig. 2
shows the phylogenetic relationships of viruses utilized in this study.
Erythrocyte agglutination properties of pandemic H1N1 and swine isolates
The collection of viruses shown in Table 1 was ﬁrst assessed for
their capacity to agglutinate erythrocytes from different species,
which are known to vary in their expression of cell-surface glycansis study. The tree was assembled using the genetic distance model HKY and the tree
risk indicate that the isolate was used in this study.
Fig. 3. Glycanmicroarray studieswere performed at the Consortium for Functional Glycomics using CFGmicroarrays. Alexaﬂuor488 labeled viruseswere incubated for 1 hour at 4 °C prior
to scanning. Glycans in the graph were sorted based on their glycan structure to groupα2,6 andα2,3 SA. Background is indicated by the red line and was determined bymultiplying the
average of all glycans on the microarray by two. (A) A/Swine/Minnesota/02749/2009 (H1N1), (B) A/Swine/Minnesota/02751/2009 (H1N1), (C) A/Swine/lllinois/02860/2009 (H1N1),
(D) A/Swine/Minnesota/02719/2009 (H3N2).
172 K.C. Bradley et al. / Virology 413 (2011) 169–182with sialic acids in the α2,3 versus α2,6 composition (Ito et al., 1997).
Chicken red blood cells (cRBCs), turkey red blood cells (tRBCs) and
guinea pig red blood cells (gpRBCs) are commonly used to
characterize inﬂuenza isolates and laboratory stocks, as these
erythrocytes contain both α2,3- and α2,6-linked glycans, with the
α2,6 conformation being predominant on gpRBCs (Medeiros et al.,
2001). By contrast, horse red blood cells (hoRBCs) contain a
predominance of cell surface glycans with sialic acids in α2,3
conﬁguration (Ito et al., 1997). Nearly all of the viruses in our panel
were found to agglutinate guinea pig erythrocytes with high
efﬁciency, while agglutination using turkey and chicken erythrocytes
were generally observed to have slightly lower HA titers (Table 2). In
contrast, among the viruses in our panel, only the A/New Caledonia/
20/1999 vaccine strain and the A/Pennsylvania/08/2008 human
seasonal strain demonstrated detectable HA titers using horse
erythrocytes, suggesting that these viruses may have the capacity to
recognize receptors in α2,3 conformation.
Glycan microarray analyses
For a more direct analysis of the receptor binding capabilities of
the viruses shown in Table 1, we utilized glycan microarray analysisFig. 4. Glycanmicroarray experiments were performed as indicated in Fig. 3, and theMaterial
(C) A/Pennsylvania/08/2008 (H1N1), (D) A/California/04/2009 (H1N1), (E) A/Mexico/IN
(H1N1), (H) H3N1 Aichi HA WT (H3N1).(Blixt et al., 2004). Puriﬁed viruses were labeled using the Alexaﬂuor
488 amine reactive dye, as described in Materials and methods, and
bound to glycan arrays provided by the Protein-Glycan Interaction
Core (Core H) of the Consortium of Functional Glycomics. The plots of
binding data are presented in histogram form in Figs. 3 and 4. The
binding results were sorted based on their glycan structure in order to
group the glycans containing terminal sialic acids on the graph. A peak
was considered to be signiﬁcant if the relative ﬂuorescence units
(RFUs) were 2× higher than the average RFUs for all the glycans
expressed on the microarray. The overall levels of binding were
variable among samples if RFUs of maximum peaks are compared;
therefore, the graphs shown in Figs. 3 and 4 have variable ranges on
the y-axis in order to provide optimal visualization of the distribution
of glycan species bound for individual samples. The structures of the
top ﬁve glycans bound by each virus are presented in diagrammatic
form in Fig. 5. These structures do not include the spacers necessary
for attaching a glycan to the glass slide.
Contemporary H1 swine isolates
To determine the receptor binding patterns of recent swine isolate
strains, three 2009 isolates were examined. The ﬁrst strain, A/swine/s andmethods. (A) A/Brisbane/59/2009 (H1N1), (B) A/New Caledonia/20/1999 (H1N1),
DRE4487/2009 (H1N1), (F) A/Texas/15/2009 (H1N1), (G) A/Swine/Iowa/1976/1931,
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Fig. 5. Top ﬁve glycans bound by puriﬁed swine isolate viruses on the CFGmicroarray. The ﬁve highest binding glycans with %CVs less than 50% are listed without the spacer used to attach glycans to the consortium slides. The %CV shown is the
number provided by glycan array analysis software. Identical structures are indicative of virus binding to glycans linked to the slide with different spacers. Nomenclature is as follows: purple diamond, Neu5Ac; yellow circle, Galactose; blue
square, GlcNAc; red triangle, fucose; OSO3, sulfate group. Linkages are indicated between sugar symbols. (A) A/Brisbane/59/2007, (B) A/New Caledonia/20/1999, (C) A/Pennsylvania/08/2008, (D) A/California/04/2009, (E) A/Mexico/
INDRE4487/2009, (F) A/Texas/15/2009, (G) H3N1 WT, (H) A/Swine/Iowa/1976/1931, (I) A/Swine/Minnesota/02749/2009, (J) A/Swine/Minnesota/02751/2009, (K) A/Swine/Illinois/02860/2009, (L) A/Swine/Minnesota/02719/2009.
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175K.C. Bradley et al. / Virology 413 (2011) 169–182Minnesota/02749/2009 (Mn/02749), revealed a highly restricted
binding phenotype, binding exclusively toα2,6 SA containing glycans,
with no binding to glycans containing α2,3 SA that did not also
contain a terminalα2,6 SA (Fig. 3A and Fig. 6D, glycans 3–5). A/swine/
Minnesota/02751/2009 (Mn/02751) also preferentially bound α2,6
SA-containing glycans (Fig. 3B), with greater binding to branched
glycans over single chain glycans (Fig. 6D, glycans 1 and 3), but the
addition of a 6′-O-SO3 did not seem to increase binding over identical
glycans lacking a sulfate (Fig. 6F, glycans 1 and 5). The receptor
binding domains of Mn/02749 and Mn/02751 are identical, with the
exception of three residues at positions 133, 193, and 219. One
difference observed for these strains was that Mn/02751 displayed
signiﬁcant binding to a single α2,3-linked N-glycolylneuraminic acid
(Neu5Gc) present on the microarray, a Neu5Gcα2,3Galβ1,4(Fucα1,3)
GlcNac glycan (Fig. 3B). However, the full breadth of Neu5Gc binding
for these two strains is difﬁcult to ascertain due to the limited number
of Neu5Gc glycans present on the microarray. We attempted to
determine how the number of sugars in the glycan chain altered
binding, but effects varied greatly depending on the type and
conformation of internal sugars and therefore do not appear to be a
major determinant of binding preference. A/swine/Illinois/02860/
2009 (Il/02860) virus is divergent from Mn/02749 and Mn/02751,
differing at several positions in the receptor binding site (Table 1).
Relative to the other swine isolates, it bound poorly to the
microarrays, recognizing less than 2/3 of the glycans bound by both
Minnesota strains (Fig. 3C). Despite the D190N mutation, previously
shown to alter receptor binding, it was also highly restricted to α2,6
SA, with preferential binding to an unbranched poly-N-acetyllactosa-
mine glycan with a terminal α2,6 SA. In addition, Il/02860 bound to
the same Neu5Gc glycan recognized by Mn/02751. However, any
trends relating to length or additional charged sugars are difﬁcult to
determine due to the overall poor binding of Il/02860 to the
microarray.
Analysis of pdmH1N1 isolates
To compare the binding of trH1N1 swine isolates with early
isolates from the pdmH1N1 outbreak, we examined three prototype
pdmH1N1 strains that were isolated from patients presenting with a
representative spectrum of disease during the early stages of the
outbreak. All three pdmH1N1 strains bound primarily α2,6 SA-
containing glycans (Fig. 4D–F), with very limited binding to glycans
with α2,3 SA. Overall, the strongest binding glycans bound by the
2009 pdmH1N1 isolates were highly restricted to the same structure
(Fig. 5D–F).
A/California/04/2009 (Fig. 4D) was isolated on 1 April from a 10-
year-old male patient, and was an early isolate of the pandemic. This
virus displayed a highly restricted α2,6 SA binding preference.
Although this virus showed slight binding to a long biantennary
structure with both α2,3 SA and α2,6 SA, the relative binding was
reduced relative to an identical glycan containing two terminal α2,6
SA (Fig. 6C glycans 3 and 4). The addition of a sulfate (6′-O-SO3) or
fucose to a glycan did not seem to affect binding of A/California to
α2,3 SA- orα2,6 SA-containing glycans, either positively or negatively
(Fig. 6E, glycans 1, 2 and 5). The glycans to which A/California bound
were long, unbranched, poly-N-acetyllactosamine glycans, and there
appeared to be a preference for structures containing Galβ1,4GlcNAc
as the second and third sugar from the terminus in the glycan chain.
A/California preferentially bound biantennary glycans present on the
microarrays over identical monoantennary glycan chains (Fig. 6,
glycans 1 and 2), but curiously, the biantennary glycan chain did not
require a terminal sialic acid on both chains to increase binding
(Fig. 6C, glycans 1, 3, and 6). This could indicate that the sialic acid on
an unbound branch of the biantennary glycan does not increase
avidity, but rather increases steric hindrancewith the globular head of
HA.A/Mexico/INDRE4487/2009 (A/Mexico) was isolated from a 29-
year-old female with a severe URT infection (Belser et al., 2010). A/
Mexico showed a similar overall binding phenotype to A/California
with a few notable differences. Again, a high preference for glycans
having terminal α2,6 SA, was observed, but in some cases, binding to
monoantennary glycans with terminal α2,3 SA was visualized above
background (Fig. 4E). In each case where A/Mexico bound a
monoantennary glycan having a terminal α2,3 SA, a fucose was
branched off of the third sugar, GlcNAc (data not shown). Interest-
ingly, the data indicated a preferential binding of A/Mexico to glycans
having a Galβ1,4GlcNac linkage at the fourth and ﬁfth sugar, as
opposed to a Galβ1,3GlcNAc at the same location (data not shown).
The A/Texas/15/2009 virus (A/Texas) was isolated from a fatal
inﬂuenza infection of a 1-year-old pediatric patient (Belser et al.,
2010). A/Texas bound similar glycans as A/Mexico, but among the
human pdmH1N1 strains examined, it showed the greatest capacity
for binding toα2,3 SA glycans (Fig. 4F). Similar to A/Mexico, all bound
glycans with a terminal α2,3 SA also contained a branched fucose off
of the third sugar, GlcNAc. Further, A/Texas bound a surprisingly large
number of non-sialylated glycans present on the microarrays, most of
which contained at least one fucose branched off of the third GlcNAc
sugar, but the signiﬁcance of this is unclear. Further studies will be
needed with additional types of fucosylated glycans to explore this
phenomenon.
Glycan microarray analysis of seasonal H1N1 vaccine strains
Three viruses were examined to compare the receptor binding
patterns of pdmH1N1 strains to those of H1N1 seasonal and vaccine
strains from previous years. A/Pennsylvania/08/2008 (A/Penn) is a
pre-pandemic seasonal H1N1 human isolate from October of the
2008–2009 inﬂuenza season, minimally passaged in MDCK cells. We
also examined the receptor binding phenotype of vaccine strains A/
Brisbane/59/2007 (A/Brisbane) and A/New Caledonia/20/1999 (A/
New Cal), which were both vaccine strains for seasonal H1N1 strains
in circulation prior to the pdmH1N1 outbreak, but their passage
history is undocumented.
The A/Penn human isolate preferentially bound glycans having
α2,6 terminal SA, but displayed some interesting characteristics that
included α2,3 SA binding as well. Notable among these were a
number of short, sulfated glycans with α2,3 terminal SA (Fig. 5C). In
fact, eight out of twelve glycans having α2,3 terminal SA that showed
signiﬁcant binding by A/Penn were either sulfated or fucosylated,
while the other four glycans were long biantennary structures with
either α2,3/α2,6 terminal SA combination or α2,3/α2,3 SA present at
the glycan termini (data not shown). In general, A/Penn bound both
branched and unbranched glycans equally, provided they contained at
least one terminalα2,6 SA. Of note, the glycanwith the second highest
level of binding was a sialylactosamine (SLN) glycan containing a
sulfate and fucose branched from the same GlcNAc (Fig. 5C, glycan 2).
This glycan was recently modeled into the H5 and H7 crystal
structures and predicted to create additional contacts with residues
K222 and K193 in H5 and H7 inﬂuenza subtypes, respectively
(Nicholls et al., 2008). All of the pdmH1N1 strains and human isolates
utilized in our study contain a K at position 222, but there is signiﬁcant
variation at residue 193 between the pdmH1N1 strains and vaccine
strains (Table 1).
The highest peaks associated with A/Brisbane binding represented
glycans having long, monoantennary, terminalα2,6 SA linked to poly-
N-acetyllactosamine glycans. We compared virus binding of glycans
having α2,3 or α2,6 SA, which revealed a clear preference for α2,6 SA
(Fig. 6A, glycans 1–4). In a comparison of the ability of A/Brisbane to
bind biantennary versus monoantennary glycans, the data showed a
preference for monoantennary counterparts (Fig. 6C, glycans 1–4).
This could indicate that long biantennary glycans create steric
hindrance in and around the receptor binding pocket, causing reduced
Fig. 6. Comparison of glycans bound on CFGmicroarrays. The fold of background is indicated. In the instance where the %CV is greater than 50%, the %CV is indicated in parenthesis. Compared glycans are all bound to the same spacer that links
the glycan to the CFG slide.
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177K.C. Bradley et al. / Virology 413 (2011) 169–182binding to the receptor. Generally, the highest binding α2,3 SA
receptors contained either a fucose or a sulfate near the glycan
terminus, and their absence lead to a reduction in binding (Fig. 6E,
glycans 1–5).
Similar to A/Brisbane, A/New Cal showed a preference for long,
monoantennary glycans with a terminal α2,6 SA, and generally bound
similar glycans as A/Brisbane (Figs. 4B and 5B). The increased binding of
A/New Cal to fucosylated glycans was less pronounced than for that
observed for A/Brisbane (Fig. 6E, glycans 1–4), but the addition of a
sulfate to the sugar near a terminal α2,3 SA clearly leads to increased
binding. Sequence analysis of the two strains indicated that the receptor
binding site is highly conserved between the two viruses, except for a
mutation, K192R, in the A/New Cal strain. Both strains contain the
D190Nmutation that is commonly associated with egg adaptation, and
has been shown to increase binding to glycans with a terminal α2,3 SA.A/Swine/Iowa/1976/1931 and H3N2 isolate glycan microarrays
We also determined the receptor binding phenotype of A/Swine/
Iowa/1976/1931 (Sw/IA/1931), a classical swine H1N1 strain, which is
a descendent of the 1918 pandemic strains that entered the North
American swine population (Shope, 1936). Sw/IA/1931 bound to a
mixture of glycans having α2,3 and α2,6 terminal SA (Fig. 4G) with a
clear preference for long poly-N-acetyllactosamine glycans having
α2,6 terminal SA (Fig. 6B, glycans 1 and 3), but did not bind well to
monoantennary glycans containing mannose sugars (Fig. 6D, glycans
1 and 2). Because the passage history of this virus is unknown, these
results are most likely representative of binding patterns acquired
during multiple passages in animals, eggs and/or tissue culture
(Francis, 1937; Horsfall et al., 1941).A
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Fig. 7. Fluorescent binding and neuraminidase activity assays of inﬂuenza isolates. For the ﬂu
for 1 hour at 4 °C, washed and scanned. Neuraminidase activity assays were performed us
20 min, and 30 min. Panels—Fluorescent binding results in panel (A) MDCK and (B) A549.Finally, we examined the receptor binding phenotype of a swine
H3N2 inﬂuenza isolate, A/swine/Minnesota/02719/2009 (swine/
02719). Similar to the H1N1 isolates, this strain also preferentially
bound glycans having α2,6 terminal SA (Fig. 3D). Interestingly,
binding to a branched glycan having terminal α2,6/α2,6 SA was
decreased relative to the binding observed for a monoantennary
glycan with similar sugar composition having a terminal α2,6 SA;
however, a branched glycan having α2,6/α2,3 SA at the termini did
not exhibit a similar decrease in binding ability (Fig. 6D, glycans 1–4).
Signiﬁcant binding to monoantennary glycans having α2,3 terminal
SA was only visualized when a sulfate was present (Fig. 6F, glycans 1
and 5). This is in contrast to binding of our H3 Aichi laboratory
adapted strain, which bound primarily α2,6 linked sialic acid, but was
still capable of binding biantennary glycans havingα2,3/α2,3 orα2,3/
α2,6 SA at their termini (Fig. 4H and Fig. 6C, glycans 4 and 5).Binding of pdmH1N1 strains to various cell monolayers
The type and distribution of cell-surface glycans vary from species
to species, and are known to vary among tissue culture cell lines. As a
complementary assay, we compared the relative binding of the
Alexaﬂuor 488 labeled pdmH1N1 and swine isolates to two different
cell lines commonly used to propagate inﬂuenza viruses: MDCK cells,
a widely-utilized canine kidney cell line, and A549 cells, a human lung
carcinoma cell line. Viruses were adsorbed to cell monolayers,
washed, and binding was quantiﬁed by ﬂuorimetry. Each strain was
normalized to theWT level of binding, and is shown as a percentage of
the laboratory strain, H3N1 WT. Fig. 7A shows that the laboratory-
adapted H3N1 strain bound extremely well to MDCK cells. In contrast,
H1N1 pdmH1N1 isolates and the swine/02749 isolate bound to MDCKB
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orescent binding assay, Alexa488 labeled inﬂuenza virus was incubated at an MOI=3.0
ing 0.01 mg MUNANA and 104 PFU of virus. Fluorescence was determined at 10 min,
Panel C—Neuraminidase assay with inﬂuenza isolates.
178 K.C. Bradley et al. / Virology 413 (2011) 169–182cells at less than 25% of WT levels (Fig. 7A). Showing intermediate
levels of binding were A/Brisbane and swine/02719 strains, which
bound 64.6% and 65.5% of WT, respectively. A comparison of relative
binding to A549 cells shows a similar pattern as that observed on
MDCK cells. The primary differences were that overall binding by all
viruses was increased in A549 cells (data not shown) and that
increased binding was observed for A/California and A/Texas strains.
The fact that A/Brisbane bound both MDCK and A549 cells greater
than any of the pdmH1N1 isolates is largely consistent with the
increased number of glycans bound on the glycan microarrays.
Relative NA activity of pdmH1N1 strains
As mentioned previously, the HA/NA functional balance has been
shown to be critical for viral ﬁtness and propagation. In order to compare
the relative neuraminidase activity of pdmH1N1 strains, we utilized the
ﬂuorescent chemiluminescent substrate methylumbelliferone N-acetyl-
neuraminic acid MUNANA, which ﬂuoresces when cleaved by a
neuraminidase. Ten thousand (104) PFU of virus was diluted with PBS
and MUNANA substrate into cold 96-well plates. Plates were then
incubated at 37 °C for 10, 20, or 30 min, at which time the reactionswere
stopped and assayed by ﬂuorimetry. Interestingly, the A/Brisbane and
H3N1 WT had increased levels of NA activity relative to the two
pdmH1N1 strains (Fig. 7C). Sequence alignments indicated few muta-
tions between the pdmH1N1NAproteins, and all catalytic sites remained
identical between pdmH1N1 strains and A/Brisbane (Colman et al.,
1983). However, a recent structural analysis of a 2009 H1N1 pdmH1N1
isolate revealed that a V149I mutation in the NA of pdmH1N1 isolates
alters the 150 loop, and appears to form a smaller catalytic pocket. This
alteration could affect the highly conserved catalytic residues D151 and
R152 (Li et al., 2010) which would most likely affect NA activity.
Discussion
The 1997 emergence of highly pathogenic strains of avian H5N1
viruses and their sporadic transmission to humans raised serious
concerns over the genesis of a new human pandemic, but fortunately,
these strains have yet to establish themselves in the human
population, or transmit readily from person to person (Miller et al.,
2009). By contrast, the current H1N1 pdmH1N1 strains spread rapidly
in the human population from the time they were ﬁrst detected, and
do not appear to be the result of multiple introduction events (Garten
et al., 2009). Understanding the molecular determinants necessary for
the adaptation of inﬂuenza viruses to humans is essential to improved
pandemic preparedness. In particular, the role of HA-mediated
receptor binding should always be examined, as this property is one
of theﬁrst obstacles to overcome for adaptation to a new species. Here,
we examined the receptor binding properties of H1N1 pdmH1N1
strains currently circulating in the human population, and compared
them to earlier seasonal H1N1 strains, as well as to trH1N1 swine
inﬂuenza isolates. Swine are of particular interest to the ecology and
emergence of inﬂuenza viruses, as that they are capable of propagating
viruses of both human and avian origins (Scholtissek et al., 1983),
which allows the segmented inﬂuenza genome to reassort in co-
infected animals, potentially giving rise to novel inﬂuenza viruses.
The early pdmH1N1 isolates examined almost exclusively recognized
α2,6-linked sialic acids. For the A/California virus, the only example of
binding to a glycan havingα2,3 SA is with a glycan that also contained a
terminal α2,6 SA (Fig. 6C, glycan 4 and data not shown). Binding of
glycans having terminal α2,3 SA by both A/Texas and A/Mexico was
highly correlated with the presence of fucose, since all monoantennary
α2,3 SA glycans bound by A/Mexico and A/Texas were fucosylated. The
2008 H1N1 seasonal strain, A/Penn, showed a preference for glycans
having a terminal α2,6 SA as well, but demonstrated a greater ability to
recognize glycans with terminalα2,3 SA than the pdmH1N1 strains that
we examined. However, similar to A/Texas andA/Mexico, themajority ofthe glycans containing terminal α2,3 SA that were bound by A/Penn
contained either a sulfate, fucose, or both.
The two glycans that were bound at the highest levels by the
pdmH1N1 isolates and theA/Penn isolatewere a simple SLNand a seven-
sugar, monoantennary, sialylated poly-N-acetyllactosamine glycan that
contained two additional fucose residues at the ﬁfth and seventh
positions in the glycan, both having terminal α2,6 SA (Fig. 5C glycan 5,
Fig. 5D glycan 3, Fig. 5E glycan 3, and Fig. 5F glycan 2). Both of these
glycans were recently shown to bind the majority of both egg-adapted
and MDCK-passaged H3N2 isolates (Stevens et al., 2010). The possibility
exists that if thepdmH1N1HAreceptorbindingafﬁnity is relativelyweak,
asmaybe indicated by the relatively lowbinding toMDCKandA549 cells
shown in Fig. 7A and B, the addition of a fucose could lead to greater
interaction with residues in the 220 loop, which has been visualized
previously in modeling experiments (Nicholls et al., 2008).
Interestingly, the H3 subtype MN/02719 was the only swine
isolate to not bind the monoantennary seven-sugar glycan with
fucoses linked to the 5th and 7th sugar residues at levels above
background (depicted in Fig. 5I, glycan 1). The other H3 virus used in
this study, the laboratory strain H3N1 WT, also did not bind the
structure, which could indicate a subtype-speciﬁc binding preference.
Swine isolates generally had the same pattern of binding as pdmH1N1
strains, consistently binding short SLN glycans (i.e., Fig. 5J, glycans 2,
3, and 5). These isolates also preferred glycans with terminal α2,6 SA
versus α2,3 SA (Fig. 6B, compare glycans 1 and 2, 3 and 4). The near
absence of α2,3 SA binding by the swine isolates utilized in this study
is interesting considering the presence of bothα2,3 andα2,6 SA in the
swine respiratory tract (Van Poucke et al., 2010). This could indicate
that a reassortment event occurring in the swine respiratory tract
could select for variants that preferentially bindα2,6 SA. However, we
note that the small sample size tested on these glycan microarrays
may not be representative of all circulating swine inﬂuenza isolates in
North America or Europe.
Overall, the results conﬁrm the hypothesis that human isolates
generally adopt high speciﬁcity forα2,6-linked terminal SA, and that this
is probably favoredovermixedordualα2,3 andα2,6 SAbinding capacity.
Previous glycan microarray binding experiments performed with
seasonal H3N2 isolates have shown a marked preference for glycans
with terminal α2,6 SA (Kumari et al., 2007), and seasonal non-egg-
adaptedH1N1 isolates bindα2,6 SLNoverα2,3 sialyllactose (Gambaryan
et al., 1999, 1997). The vaccine strains, A/Brisbane and A/New Cal, bound
to glycans having bothα2,3 andα2,6 terminal SA, but this is likely due to
repeated passage through eggs, rather than an accurate reﬂection of the
binding preferences of the original strain.We obtained similar results for
A/Swine/1976/1931 virus, the classical swine inﬂuenza isolate, and this
also is likely to reﬂect an extensive laboratory passage history that
included replication in eggs. Although it has been known for decades
(Burnet and Bull, 1943), these results emphasize the importance of
passage history for any viruses to be analyzed for receptor binding
properties. Even minimal passage in eggs is likely to select for mutants
with altered binding proﬁles (Burnet and Bull, 1943; Gambaryan et al.,
1999; Katz et al., 1990; Katz and Webster, 1988; Lugovtsev et al., 2009;
Robertson et al., 1987, 1985; Stevens et al., 2010). Although the use of
MDCK cells may not be the ideal substitute for ampliﬁcation of virus
stocks, it would appear to be preferable to eggs for binding studies, at
least for human and swine isolates (Stevens et al., 2010).
Data from numerous laboratory studies, and observations of
evolving phenotypes of early strains in the 1957 and 1968 pandemics
indicate that the HA and NA proteins operate in a reciprocal balance
due to their opposing functions (Mitnaul et al., 2000; Wagner et al.,
2002, 2000). Viruses with a tightly binding HA coupled with a weak
NA protein have difﬁculty releasing from cell membranes upon viral
release, while poorly binding HA and a strongly active NA may
prevent efﬁcient binding to glycans present on the cell membrane. In
experiments examining NA activity, we found that pdmH1N1 isolates
had relatively weak neuraminidase activity, indicating that the HA
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period of time the pdmH1N1 strains have been predicted to be
circulating undetected in nature (Smith et al., 2009). The role of the
neuraminidase in viral infection has been linked to cleaving sialic acids
present on the cell surface, as well as in releasing mucin bound virus.
Human mucins have been shown to contain a abundance of glycans
having α2,3 terminal SA and are known to be inhibitory to inﬂuenza
strains (Burnet, 1948; Couceiro et al., 1993). These data, in combination
with the predominance of α2,6 SA found in the upper respiratory tract
of humans (Shinya et al., 2006), could indicate a selective advantage for
strains that bind strictly to glycans containing terminal α2,6 SA over
those with dual speciﬁcity. Presumably, virus strains that bind glycans
containing either α2,3 or α2,6-linked terminal SA can evade the upper
respiratory mucins with a weakly binding HA, but the lack of glycans
containing α2,3 SA in the upper respiratory tract could lead to poor
transmission capabilities (Maines et al., 2006; Shinya et al., 2006).
The overall binding levels observed for pdmH1N1 strains and
contemporary swine H1N1 viruses seemed to be low relative to H3N1
WT and vaccine isolates. This was reﬂected in our ﬂuorescent binding
assays, and we also observed high PFU:HA titer ratios for these viruses
(data not shown). Glycosylation in the globular head of HA has been
associated with weaker binding (Wagner et al., 2000), but in the
pdmH1N1 strains, no additional glycosylation is present that could
cause steric hindrancewith anypotential receptor (Igarashi et al., 2010).
Alternatively, the possibility exists that the strains are binding to host
glycans that are not present on the microarray. The current glycan
microarray consists of approximately 500 glycans, but the overall
mammalian glycome is likely to be much larger with a larger set of
glycan determinants (Cummings, 2009). In addition, swine, unlike
humans, expressNeu5Gcon their cellmembranes, and there is evidence
that swine, but not human inﬂuenza strains recognize Neu5Gc (Suzuki
et al., 1997). Because the glycan microarrays used in this study contain
fewer than ten Neu5Gc glycans, an absence of binding may not
necessarily indicate an inability to bind. However, the weak binding of
pdmH1N1 isolates observed in our studies may, in fact, be reﬂective of
their inherent biology. Weak HA binding might confer a selective
advantagewith regard to transmission efﬁciency, as there are examples
withother viruses ofweaker bindingallowing for greater dissemination,
systemic spread, and increased pathogenicity within a host animal
(Byrnes and Grifﬁn, 2000; Stehle and Harrison, 1996).
The viruses examined here differ at several positions in and around
the glycan receptor binding site (Table 1 and Fig. 1), although it is not
currently possible to directly correlate binding properties to the
presence of particular residues at speciﬁc HA positions. For H1 viruses
such as those responsible for the 1918 pandemic, mutations at
positions 190 and 225 have been shown to heavily inﬂuence a strains
ability to bind glycans having α2,3 versus α2,6 terminal SA; however,
these residues are unchanged between the A/Penn, pdmH1N1, and
trH1N1 isolates (Table 1). Residues in the receptor binding site that
are altered include 133, 136, 138, 192, 193, 219, 227, and 230 (H3
numbering). With the exception of 136 and 138, most of these
residues do not contact sialic acid directly but may interact with
contact residues, or potentially interact with internal sugars of the
glycan receptor. In the case of glycans with α2,6 SA, mutations at 219
and 227 are thought to interact with internal sugar residues in the
glycan, as are residues 192 and 193, which were recently modeled to
interact with a Glc5 sugar in glycans similar to those found in Fig. 6A
(Maines et al., 2009). Structural interpretations for binding to glycans
with α2,3 SA are more difﬁcult to determine, largely due to the
reduced electron density for such receptors beyond the 3rd sugar
residue in HA receptor complexes (Gamblin et al., 2004). However, as
discussed previously, a sulfate or fucose on the 3rd sugar residue of a
receptor could potentially interact with the residues at 222 or 193.
Another of these mutations, I230M, has been observed previously by
selection in mice during passage of an H3 Y98F mutant with reduced
receptor binding activity (Meisner et al., 2008). This residue isconsidered to be a “second shell”mutation, in that it does not directly
interact with sialic acid, but appears to interact with the Y98 residue,
potentially altering the structure of the glycan binding pocket. It is
interesting that the two strains associated with severe disease, A/
Texas and A/Mexico, bound several glycans with terminal α2,3 SA.
Although increased α2,3 binding has been associated with higher
pathogenicity in the past (Hatta et al., 2001; Liu et al., 2010; Shinya et
al., 2005) and has been observed to correlate in one case with changes
at position 225 (Chen et al., 2010), differences in patient age, as well
as unknown patient history, make concrete conclusions relating to
pathogenicity difﬁcult to determine.
Increased surveillance and improved techniques have vastly
increased our ability to identify potential pandemic strains in swine
and avian species. However, the combinations of conditions necessary
for a strain to efﬁciently transmit to humans from another species are
not well understood. Inﬂuenza infection and transmission in a new
host species are clearly a multifactorial trait, but as the HA and NA are
critical to the initial events of infection and transmission, it is
important to examine the characteristics of early pandemic isolates
and compare them to closely related strains. Such studies maymake it
possible to identify critical properties of viruses with a greater
likelihood for initiating new pandemics.Materials and methods
Viruses and cells
Inﬂuenza virus stocks for glycanmicroarray analysis were grown in
cell culture using standard methods. In brief, Madin-Darby Canine
Kidney (MDCK) cells (ATCC, Manassas, VA) were seeded into 75 cm2
or 175 cm2 tissue culture ﬂasks and grown in DMEM (Hyclone, Logan,
UT), 5% FBS, 2 mML-glutamine until approximately 90% conﬂuent
(~8×106 cells total). Cells were rinsed twice with 1× PBS and 5 ml
MEM (Hyclone) with TPCK-treated trypsin (10 μg/ml, Worthington
Biochemical, Lakewood, NJ) was added to each ﬂask. Original stock
virus was added at 1:100 dilution in 5 ml MEM/TPCK trypsin and
incubated 2–4 hours at 37 °C, 5% CO2 before an additional 5 ml of
MEM/TPCK trypsin was added. Infection continued for 48–72 hours
and was monitored for CPE. Supernatant was harvested and
centrifuged at 1000 rpm, 5 min to clarify cell debris. Virus titer was
evaluated by a hemagglutination (HA) and plaque assay and/or TCID50
on MDCK cells. Viral RNA was puriﬁed using a QiaAmp Viral RNA
puriﬁcation kit (Qiagen), and reverse transcribed using SuperScript III
1st strand synthesis (Invitrogen). TheHA andNAgeneswere ampliﬁed
using HA- or NA-speciﬁc primers designed according to published
sequences on the Inﬂuenza Research Database (www.ﬂudb.org).
The human inﬂuenza viruses used in these studies were kindly
provided by Drs. Alexander Klimov and Xiyan Xu at the Centers for
Disease Control and Prevention (Atlanta, GA): A/California/04/09, A/
Mexico/INDRE4487/09, A/Texas/15/09, A/Brisbane/59/2007, A/New
Caledonia/20/99, and A/Pennsylvania/08/2008. The recent swine
inﬂuenza viruses used in this study were isolated by the University
of Minnesota Veterinary Diagnostic Laboratory (Saint Paul, MN): A/
Swine/MN/02719/2009, A/Swine/MN/02749/2009, A/Swine/MN/
0251/2009, A/Swine/IL/02861/2009. The classical swine H1N1 A/
Swine/1976/31 was kindly provided by Dr. Richard Webby (St. Jude
Children's research Hospital, Memphis, TN).Virus puriﬁcation
Harvested virus was puriﬁed through a 25% sucrose cushion in NTE
buffer, consisting of 100 mM NaCl, 10 mM Tris buffer, and 1 mM
EDTA. Viruses were centrifuged for 3 hours at 28,000 rpm, resus-
pended in NTE buffer, and kept frozen at −80 °C until needed.
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Puriﬁed inﬂuenza strains were labeledwith the amine reactive dye
Alexaﬂuor488 (Invitrogen). Twenty-ﬁve micrograms of amine reac-
tive Alexa 488 was incubated with 100 μl of virus and 1 M NaHCO3
(pH 9.0) for 1 hour. The labeled virus was dialyzed overnight in a 7000
MWCO Slide-A-Lyzer MINI dialysis unit (Thermo Scientiﬁc) against
PBS+1 mM EDTA, and binding experiments were carried out by
members of the CFG Core H facility. HA titers were monitored before
and after labeling to ensure labeling did not alter receptor binding
capabilities. Viral titers for glycan microarray studies were as follows:
A/Penn—6.2×106 PFU/ml; A/California—1.9×107 PFU/ml; A/Mexico—
4.3×106 PFU/ml; A/Texas—1.4×107 PFU/ml; A/Brisbane—1.7x106
PFU/ml; A/New Cal—3.2×107 PFU/ml; Sw/IA/1976—4.7×106; MN/
02719—2.6×106; MN/02749—1.8×107 PFU/ml; MN/02751—2.4×106
PFU/ml; IL/02860—1.8×105 PFU/ml.Glycan microarrays and analysis
Core H of the Consortium of Functional Glycomics performed
glycan microarray binding experiments (www.functionalglycomics.
org) using CFG array version 4.0 or 4.1. Brieﬂy, 70 μl of ﬂuorescently
labeled virus was incubated on a glycan microarray slide at 4 °C for
1 hour, prior to scanning by a Perkin-Elmer ProScanAray. Signiﬁcant
peaks were determined by averaging the relative ﬂuorescent units
(RFU) of all glycans on the microarray, which was then multiplied by
two to determine the background RFU level. Finally, any glycans
above background with a %CV of greater than 50% were not
considered to be signiﬁcant.Fluorescent binding assays
Live inﬂuenza viruses were labeled in the same manner as strains
prepared for glycan microarrays. Fully conﬂuent MDCK, A549 and PT-
K75 cell lines were chilled at 4 °C for 1 hour prior to inﬂuenza binding.
104 PFU of labeled virus was bound and incubated on chilled cell lines
at 4 °C for 1 hour, washed 3 times with cold PBS, and scanned using a
Biotek Synergy 2 ﬂuorimeter using a bottom optics position and
excitation/emission of 485/528.NA activity assays
Cold 96-well plates were kept on ice while cold PBS, 104 PFU of
virus, and 0.01 mg MUNANA (Invitrogen) were added to each well.
Plates were placed in a 37 °C incubator and reactions stopped at 10,
20, and 30 min using 1 M Glycine (pH 10.7). After the stop solution
was added, plates were scanned using a Biotek Synergy 2 ﬂuorimeter
using an excitation/emission of 360/460 respectively. Each virus at
each time point was performed in triplicate and the ﬂuorescence from
a mock well containing only PBS and 0.01 mg MUNANA was
subtracted from the mean ﬂuorescence obtained from each condition
tested. NA activity was determined by subtracting the mock well from
the virus-treated well, and divided by the number of seconds passed
since the plates had been place at 37 °C.Acknowledgments
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